New Hampshire · 2026 Regular Session · Bill

HB 1292: expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.

In committee Last action October 6, 2026: Interim Study Report: Recommended for Future Legislation 10/05/2026 (Vote 7-6; )

Plain-language summary

HB 1292 is a bill introduced in the New Hampshire House on December 1, 2025. According to its official title, it concerns: expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act. Primary sponsor: Erica Layon (Republican). It lists 9 additional sponsors. Most recent recorded action (October 6, 2026): Interim Study Report: Recommended for Future Legislation 10/05/2026 (Vote 7-6; ).

Sponsors

Primary sponsor: Erica Layon (Republican). 9 co-sponsors.